CStone Pharmaceuticals current ratio

The Current Ratio as of November 2026 (TTM) for CStone Pharmaceuticals (CSPHF) is 3.58

According to CStone Pharmaceuticals’s latest financial reports and current stock price. The company's current Current Ratio is 3.58. This represents a change of 62.78% compared to the average of 2.20 of the last 4 quarters.

CStone Pharmaceuticals (CSPHF) Historical Current Ratio (quarterly & annually)

How has CSPHF Current Ratio performed in the past?

The mean historical Current Ratio of CStone Pharmaceuticals over the last ten years is 4.02. The current 3.58 Current Ratio has changed -10.84% with respect to the historical average. Over the past ten years (40 quarters), CSPHF's Current Ratio was at its highest in in the June 2019 quarter at 40.27. The Current Ratio was at its lowest in in the June 2017 quarter at 0.

CStone Pharmaceuticals (CSPHF) Current Ratio by Quarter and Year

Discovering the peaks and valleys of CStone Pharmaceuticals Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

CStone Pharmaceuticals (CSPHF) Average Current Ratio

How has CSPHF Current Ratio performed in the past?

The current Current Ratio of CStone Pharmaceuticals (CSPHF) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

CStone Pharmaceuticals (CSPHF) Current Ratio vs. Peers

How is CSPHF’s Current Ratio compared to its peers?

CStone Pharmaceuticals’s Current Ratio is less than HUTCHMED (China) Limited (5.64), greater than Zai Lab Limited (2.13), greater than ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (2.66), greater than Shanghai Henlius Biotech, Inc. (0.78), greater than Mabwell-b (1.53), less than InnoCare Pharma Limited (4.16), greater than Edding Genor Group Holdings Limited (1.00), less than Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (6.34), greater than Nanjing Leads Biolabs Co Ltd (2.41), less than Antengene Corporation Limited (4.95),

Build a custom stock screener for CStone Pharmaceuticals (CSPHF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CStone Pharmaceuticals using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

CStone Pharmaceuticals (CSPHF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like CStone Pharmaceuticals or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.